U. Hollenstein et al., INFECTIOUS COMPLICATIONS OF IMPLANTABLE C ARDIOVERTER DEFIBRILLATORS - CASE-REPORT AND LITERATURE-REVIEW/, Acta medica austriaca, 23(5), 1996, pp. 164-167
Implantable cardioverters/defibrillators have greatly improved surviva
l in patients with malignant ventricular arrhythmias. As modern device
s and technical skill and experience reduce surgical complications att
ention is focussed on the potentially lethal infections of these devic
es. Staphylococcus spp. can be isolated as the predominant causative o
rganisms. Devices that require thoracotomy (as opposed to transvene sy
stems) and generator replacement (as opposed to primary implantation)
carry a higher risk of infections. Although there are sporadic reports
on successful conservative management of ICD infection, explantation
of the generator, leads and patches followed by reimplantation of a ne
w device after no less than 2 weeks is still the recommended procedure
. Concomitant intravenous antibiotic therapy should be continued for 4
to 6 weeks.